Taiho Pharmaceutical Co., Ltd., company information, Employees & Contact Information

Taiho Oncology and Taiho Pharmaceutical Announce U.S. FDA Acceptance of Supplemental New Drug Application for INQOVI® in Combination with Venetoclax to Treat Patients with Acute Myeloid Leukemia PR Newswire

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech GlobeNewswire

Taiho Pharmaceutical, Taiho Oncology, and Cullinan Therapeutics Announce Primary Endpoint Met in Phase 2b Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy PR Newswire

Firm Advises Taiho Pharmaceutical on Acquisition of Araris Biotech for Up to $1.1 Billion Wilson Sonsini

SkyDrive Receives Pre-order for SD-05 eVTOL Aircraft from TAIHO Co.,Ltd. AeroMorning.com

4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion GlobeNewswire

Taiho and Lung Therapeutics Enter Into an Exclusive License Agreement in Japan for LTI-01, Treatment for Loculated Pleural Effusions Business Wire

Nuntius Therapeutics Announces Collaboration with Taiho Pharmaceutical to Develop Next-Generation mRNA Therapies Using Nuntius’ Proprietary Cell-Specific Delivery Technology Business Wire

Taiho Ventures Expands Investment Pool to $400 Million to Continue Quality Investments and Accelerate Open Innovation PR Newswire

European Commission Grants Conditional Marketing Authorization for Taiho's LYTGOBI® Tablets for the Treatment of Adults With Cholangiocarcinoma PR Newswire

Cullinan Oncology and Taiho Pharmaceutical Announce GlobeNewswire

Taiho Oncology, Inc. Announces Establishment of European Headquarters PR Newswire

FDA Grants Breakthrough Therapy Designation for Taiho Oncology's Futibatinib for Treatment of Advanced Cholangiocarcinoma PR Newswire

Taiho Oncology Announces Acceptance of Abstract for Zipalertinib at the ESMO Congress 2025 PR Newswire

FDA Approves Taiho's LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma PR Newswire

Stephen Yoder, MD, MBA Named Vice President, Business Development, at Taiho Oncology, Inc. PR Newswire

Taiho Oncology Announces Agreement with Otsuka to Commercialize Astex Pharmaceuticals' Drug Candidates PR Newswire

Taiho Oncology Data at ASH Annual Meeting Highlight Progress in Oral Therapies for Patients with Blood Cancers PR Newswire

Taiho Oncology and Astex Pharmaceuticals Announce Data Presentations at the 65th ASH Annual Meeting PR Newswire

Whitten named president of Taiho Oncology The Cancer Letter

SkyDrive receives pre-order for SD-05 eVTOL aircraft from Taiho Vertical Mag

Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer Wiley Online Library

REZILIENT3 Global First-Line Trial of Zipalertinib Launched in Patients With Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations PR Newswire

Taiho Ventures Invests in Arcus Biosciences, Inc. as Part of $70 Million Series B Investment Round PR Newswire

PATENT—D. Del.: MSN Laboratories’... VitalLaw.com

FDA Approves LONSURF® (trifluridine/tipiracil) in Combination With Bevacizumab for Adult Patients With Metastatic Colorectal Cancer (mCRC) PR Newswire

Full article: Pimitespib for the Treatment of Advanced Gastrointestinal Stromal tumors and Other Tumors Taylor & Francis Online

Schroders Capital Global Innovation’s Araris Biotech sold to Taiho Pharmaceutical QuotedData

Taiho goes Pearl diving, brings up $405M Cullinan deal BioWorld MedTech

Taiho Oncology Names Timothy Whitten President PR Newswire Canada

Taiho to Acquire Araris Biotech in $1.14B Deal USA Herald

Fresh start for stable founded by legendary yokozuna Taiho The Japan Times

Taiho Paint Coatings World

Taiho Pharma Canada: Delivering a patient-focused approach The Japan Times

Delhi HC Quashes IPO's Patent Rejection of Taiho Pharma's Cancer Drug, Orders Re-evaluation Medical Dialogues

Anti-Cancer Patent Refusal Set Aside for Not Identifying ‘Known Substance’ BananaIP

Notice of the Reorganization of Three Otsuka Group Companies (Otsuka Pharmaceutical Factory, Otsuka Warehouse, and Taiho Pharmaceutical) as Wholly Owned Direct Subsidiaries｜July 25, 2008｜News Releases | Otsuka Pharmaceutical Co., Ltd. otsuka.co.jp